GT Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
GT Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • GT Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 2.23M shares, a 94.6% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.23M -39.2M -94.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 2.23M -38.4M -94.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.38M -35.5M -96.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.38M +290K +26.6% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 41.4M +8.91M +27.4% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 40.6M +9.95M +32.4% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 36.9M +4.54M +14% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1.09M -31M -96.6% Dec 31, 2022 10-K 2024-03-26
Q3 2022 32.5M +2M +6.55% Sep 30, 2022 10-Q 2022-10-31
Q2 2022 30.7M +2.55M +9.06% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 32.3M +11.8M +57.7% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 32.1M +26.8M +514% Dec 31, 2021 10-K 2023-03-30
Q3 2021 30.5M -47M -60.6% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 28.1M -47.3M -62.7% Jun 30, 2021 10-Q/A 2021-12-29
Q1 2021 20.5M -50.1M -70.9% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 5.22M +1.11M +27.1% Dec 31, 2020 10-K 2022-03-28
Q3 2020 77.5M +10.6M +15.9% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 75.4M +22.8M +43.3% Jun 30, 2020 10-Q/A 2020-08-18
Q1 2020 70.6M +19.2M +37.4% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 4.1M -46.5M -91.9% Dec 31, 2019 10-K 2021-04-16
Q3 2019 66.9M +16.7M +33.2% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 52.6M +2.53M +5.04% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 51.4M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 50.7M +533K +1.06% Dec 31, 2018 10-K 2020-03-27
Q3 2018 50.2M +460K +0.92% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 50.1M +49.6M +9995% Jun 30, 2018 10-Q 2018-08-14
Q4 2017 50.1M +50M +47990% Dec 31, 2017 10-K 2019-03-29
Q3 2017 49.8M +21.5M +76.4% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 496K -25.4M -98.1% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 123M +101M +467% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 104K -2.3M -95.7% Dec 31, 2016 10-K 2018-03-01
Q3 2016 28.2M -563M -95.2% Sep 30, 2016 10-Q/A 2018-02-28
Q2 2016 25.9M -566M -95.6% Jun 30, 2016 10-Q/A 2018-02-28
Q1 2016 21.7M -574M -96.4% Mar 31, 2016 10-Q/A 2018-02-28
Q4 2015 2.4M +33.4K +1.41% Dec 31, 2015 10-K/A 2018-02-28
Q3 2015 592M 0 0% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 592M +18.7M +3.26% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 596M +22.7M +3.96% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 2.37M -571M -99.6% Dec 31, 2014 10-K/A 2018-02-28
Q3 2014 592M +18.7M +3.26% Sep 30, 2014 10-Q 2015-01-08
Q2 2014 573M 0 0% Jun 30, 2014 10-Q 2015-01-08
Q1 2014 573M 0 0% Mar 31, 2014 10-Q 2015-01-08
Q4 2013 573M +72.5M +14.5% Dec 31, 2013 10-K 2015-03-31
Q3 2013 573M +116M +25.3% Sep 30, 2013 10-Q 2014-12-17
Q2 2013 573M +209M +57.3% Jun 30, 2013 10-Q 2014-12-12
Q1 2013 573M +273M +90.8% Mar 31, 2013 10-Q 2014-12-10
Q4 2012 501M +231M +85.9% Dec 31, 2012 10-K 2015-01-08
Q3 2012 457M +219M +91.6% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 364M +155M +73.9% Jun 30, 2012 10-Q/A 2012-09-13
Q1 2012 300M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 269M +120M +80% Dec 31, 2011 10-K 2014-11-18
Q3 2011 239M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 209M Jun 30, 2011 10-Q/A 2011-09-12
Q4 2010 150M Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.